Clinical Trials Directory

Trials / Completed

CompletedNCT00233142

Expressive Writing for Reducing Stress and Diabetic Symptoms in Diabetes Patients

Expressive Writing: Complementary Treatment for Diabetes

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
187 (actual)
Sponsor
Syracuse University · Academic / Other
Sex
All
Age
25 Years – 75 Years
Healthy volunteers
Not accepted

Summary

This study will determine whether the psychological benefits of expressive writing extend to diabetic patients, how long the benefits will last, and whether additional expressive writing "booster" sessions will lead to greater and more sustained improvement in diabetes symptoms and well-being.

Detailed description

Diabetes is one of the leading causes of blindness, kidney failure, and nontraumatic lower extremity amputation in the United States. Conditions such as stress and depression have been shown to worsen diabetic symptoms. Data indicate that expressive writing (an activity during which individuals deal with stressful experiences by writing about them on paper) has beneficial effects on psychological and physiological outcomes. This study will determine whether diabetes patients can benefit from expressive writing. This study will also determine the duration of the benefits and the effectiveness of booster sessions in improving their diabetic symptoms. Participants will be randomly assigned to engage in expressive writing or neutral writing for 18 months. Participants in the expressive writing group will write about traumatic or stressful events; participants in the neutral writing group will write about neutral topics that do not affect them emotionally. Some participants in the expressive writing group will receive an additional 4 months of booster sessions of expressive writing. All participants will undergo interviews, blood collection, physical exams and complete clinical scales on their disease status, quality of life, and psychological well-being; these assessments will occur at study entry, every 4 months during the study, and at the end of the study.

Conditions

Interventions

TypeNameDescription
BEHAVIORALExpressive writingWriting as therapeutic intervention
BEHAVIORALNeutral writingNon-expressive writing

Timeline

Start date
2005-09-01
Primary completion
2009-02-01
Completion
2009-02-01
First posted
2005-10-05
Last updated
2016-04-15

Locations

4 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT00233142. Inclusion in this directory is not an endorsement.